NYSE · Health Care

GLOBUS MED INC GMED

Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.

Medical/Dental Instruments

Company profile

Business mix

  • The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices.
  • It also provides orthopedic trauma solutions, including limb reconstruction, fracture plating, intramedullary nailing, external fixation, and compression screw technologies.
  • In addition, the company offers ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures.
  • Further, it distributes human cells, tissues, and cellular and tissue-based products. The company sells its products through direct and distributor sales representatives; and independent sales agents.

Current key questions

  • Can the company's products, services, or pipeline expand adoption within medical devices?
  • How do reimbursement, regulation, clinical data, patents, and commercial execution affect growth?
  • Can margins and cash flow improve while funding research, manufacturing, or go-to-market investment?
Holders 1 Current sample portfolio
Public mentions 0 Videos / interviews / letters
Valuation snapshot
PE 18.65 FCF 5.62% Buyback 1.66%
2026-06-07

Current firm holders

Firm Weight Value Filing period
Bridgewater Associates Ray Dalio 0.1% $28.5M 2026-03-31

Recent trading changes over the last 4 quarters

Net buyers 1 Last 4 13F filing periods
Net reducers 0 Last 4 13F filing periods
Unchanged holders 0 Share count unchanged
Increase amount $17.0M Estimated from net added shares
Reduction amount $0 Estimated from net reduced shares
Net share change / base shares +148.3% +197,351 / 133,112
Bridgewater Associates Ray Dalio 4 filing periods
13F 2025-06-30 Filed 2025-08-13
Major increase Shares 228.0% 13F value change +$16.0M
13F 2025-09-30 Filed 2025-11-13
Minor increase Shares 5.6% 13F value change +$636,248
13F 2025-12-31 Filed 2026-02-13
Major reduction Shares -38.4% 13F value change -$1.6M
13F 2026-03-31 Filed 2026-05-15
Major increase Shares 16.3% 13F value change +$3.7M
Settlement As of 13F 2026-03-31 · Filed 2026-05-15
Base shares 133,112 Last 4 periods +197,351 (+148.3%) Total shares 330,463 Value $28.5M

Recent mentions

No public mentions.